当前位置：首页 > 文献互助 > 互助详情

期刊论文Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis复制

用户anbt0_mWgNQY 1小时前 28 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-24 10:27:27 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1053/j.gastro.2026.03.010复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0016508526002568复制

其他信息:

出版社: Elsevier BV
作者: Benjamin H. Mullish

上一篇：Progression-Free Survival in Metastatic Breast Cancer by Local Investigators vs Blinded Independent Central Review: A Systematic Review and Meta-Analysis

下一篇：Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction …

互助时间线

2026-07-17 10:35:17 [完结求助]

楼主确认了生活万岁应助的文件是正确的, 求助状态变成已完结

2026-07-17 10:27:27 [上传文件]

生活万岁上传了文件(pdf 129.07 KB), 求助状态变成待确认

2026-07-17 10:08:02 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 2分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 19分钟前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 31分钟前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 36分钟前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 37分钟前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 47分钟前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 52分钟前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 55分钟前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前

Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前